Australian shares edge higher as CSL deal lifts healthcare stocks

By Reuters News

By Jasmeen Ara Islam Shaikh

Oct 5 (Reuters) - Australian shares closed slightly higher on Monday, with a rally in biopharmaceutical giant CSL boosting healthcare stocks in thin holiday trade.

The benchmark S&P/ASX 200 index .AXJO closed 0.1% higher at 8,686.40 points, after rising as much as 0.6% earlier in the session. The index had gained 0.8% on Friday. Several Australian states were closed on Monday for a public holiday.

Globally, investors scaled back bets on a Federal Reserve rate hike this month after softer-than-expected US jobs data on Friday, though uncertainty over the inflation outlook kept the prospect of further tightening alive.

At home, the Reserve Bank of Australia last week raised rates to a 15-year high of 4.6%, citing persistent inflation and signalling it remained open to additional tightening if needed.

"With the cash rate now more clearly in restrictive territory and some signs the economy has slowed, each further incremental increase in rates is now a tougher call," analysts at NAB said in a note.

"Inflation remains well above target and cost pressures remain elevated, but the outlook for the labour market (and activity) will become increasingly important."

The benchmark 10-year yield rose 1 basis point to 5.346%, as inflation concerns continued to weigh on bonds.

Healthcare stocks .AXHJ rose 0.7% in their best session in a week. CSL CSL.AX climbed 0.9% after agreeing to a deal worth up to $1.6 billion with Swiss biotech Alentis Therapeutics to co-develop and co-promote treatments for rare kidney and liver diseases.

Miners .AXMM ended up 0.4%, helped by strength in iron ore and copper prices. Rio Tinto RIO.AX and BHP BHP.AX gained 0.7% and 1.1%, respectively. IRONORE/ MET/L

Consumer discretionary .AXDJ and staple stocks .AXSJ slipped 0.9% and 0.4%, respectively, while real estate stocks .AXRE fell for a third consecutive session, ending 0.4% lower.

Across the Tasman Sea, the New Zealand benchmark S&P/NZX 50 index .NZ50 ended up 0.1% at 13,699.02 points.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.